Karyopharm Therapeutics Inc. is a pharmaceutical company focused on the discovery and development of drugs for the treatment of cancer and other diseases. The company develops therapies targeting nuclear transport mechanisms. It is engaged in regulatory submissions, commercialization efforts, and partnerships with third parties, with an emphasis on oncology drug development and approval processes.
expected 2026-12-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-13 | 2025-12-31 | 0001193125-26-049397 | EDGAR | 132K words |
| 2025-02-19 | 2024-12-31 | 0000950170-25-022765 | EDGAR | 128K words |
| 2024-02-29 | 2023-12-31 | 0000950170-24-022650 | EDGAR | 117K words |
| 2023-02-17 | 2022-12-31 | 0000950170-23-003129 | EDGAR | 113K words |
| 2022-03-01 | 2021-12-31 | 0000950170-22-002548 | EDGAR | 116K words |
| 2021-02-24 | 2020-12-31 | 0001193125-21-054811 | EDGAR | 117K words |
| 2020-02-26 | 2019-12-31 | 0001193125-20-049115 | EDGAR | 117K words |
| 2019-02-28 | 2018-12-31 | 0001193125-19-057610 | EDGAR | 112K words |
| 2018-03-15 | 2017-12-31 | 0001193125-18-084024 | EDGAR | 96K words |
| 2017-03-16 | 2016-12-31 | 0001193125-17-084396 | EDGAR | 88K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-13 | 2026-06-30 | 0001193125-26-347906 | EDGAR | 71K words |
| 2025-11-03 | 2025-09-30 | 0001193125-25-261667 | EDGAR | 73K words |
| 2025-08-11 | 2025-06-30 | 0000950170-25-106238 | EDGAR | 71K words |
| 2025-05-12 | 2025-03-31 | 0000950170-25-069231 | EDGAR | 65K words |
| 2024-11-05 | 2024-09-30 | 0000950170-24-121076 | EDGAR | 66K words |
| 2024-08-06 | 2024-06-30 | 0000950170-24-091210 | EDGAR | 64K words |
| 2024-05-08 | 2024-03-31 | 0000950170-24-055672 | EDGAR | 59K words |
| 2023-11-02 | 2023-09-30 | 0000950170-23-057754 | EDGAR | 59K words |
| 2023-08-02 | 2023-06-30 | 0000950170-23-036780 | EDGAR | 59K words |
| 2023-05-04 | 2023-03-31 | 0000950170-23-017483 | EDGAR | 55K words |
| 2022-11-03 | 2022-09-30 | 0000950170-22-021917 | EDGAR | 57K words |
| 2022-08-04 | 2022-06-30 | 0000950170-22-014788 | EDGAR | 58K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-18 | 0001193125-26-395517 | EDGAR | 36K words |
| 2026-09-11 | 0001193125-26-388621 | EDGAR | 21K words |
| 2026-08-31 | 0001193125-26-375495 | EDGAR | 1K words |
| 2026-08-13 | 0001193125-26-347897 | EDGAR | 5K words |
| 2026-07-31 | 0001193125-26-326995 | EDGAR | 2K words |
| 2026-07-17 | 0001193125-26-307964 | EDGAR | 1K words |
| 2026-03-27 | 0001503802-26-000011 | EDGAR | 1K words |
| 2026-03-24 | 0001193125-26-120770 | EDGAR | 3K words |
| 2026-03-03 | 0001503802-26-000006 | EDGAR | 4K words |
| 2026-02-19 | 0001193125-26-059349 | EDGAR | 1K words |
267 total filings indexed. 235 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001503802 |
| Ticker | KPTI |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.karyopharm.com |
| Listed | 2013-11-06 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/KPTI (~200 tokens, structured JSON with cryptographic provenance)